CorMedix Therapeutics: Pneumonia trials

The registry lists 10 Pneumonia studies with CorMedix Therapeutics as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 3Phase 3 6No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial PneumoniaCompletedNCT02679573Phase 3Results posted
• Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaTerminatedNCT02605122Phase 2/3Results posted
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in AdultsCompletedNCT02168946Phase 3Results posted
• Safety and Efficacy Study of Oxazolidinone to Treat PneumoniaCompletedNCT00640926Phase 2Results posted
• Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy AdultsCompletedNCT03534622Phase 1
• A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial PneumoniaWithdrawnNCT03006679Phase 3
• Study of Cases of Serious Infections Due to Carbapenem-Resistant EnterobacteriaceaeCompletedNCT02420366
• Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedNCT01968733Phase 3
• Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedNCT01756339Phase 3
• Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial PneumoniaCompletedNCT01168713Phase 2